Down 63%, Should You Buy the Dip on Pfizer?

finance.yahoo.com/news/down-63-buy-dip-pfizer-124500642.html

In This Article:
Key Points
-
Pfizer's woes range from a failed weight loss drug to tariffs and political uncertainty.
-
Yet, Pfizer maintains a strong financial foundation and a promising pipeline.
-
The stock's valuation is so low that even modest success could jumpstart the…

This story appeared on finance.yahoo.com, 2025-05-24 12:45:00.
The Entire Business World on a Single Page. Free to Use →